ENLV
Enlivex Therapeutics Ltd
NASDAQ: ENLV · HEALTHCARE · BIOTECHNOLOGY
$0.82
-0.46% today
Updated 2026-05-01
Market cap
$197.61M
P/E ratio
0.03
P/S ratio
—
EPS (TTM)
$25.48
Dividend yield
—
52W range
$1 – $2
Volume
0.6M
Enlivex Therapeutics Ltd (ENLV) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | — | — | — | — | — | — | $-149000.00 | $-865000.00 | $-4.41M | $-13.25M | $-15.49M | $-6.35M | $-3.16M | $-7.04M | $-11.01M | $-17.54M | $-23.95M | $-23.52M | $-13.01M | $-10.42M |
| Capital expenditures | $936000.00 | $461000.00 | $418000.00 | $389000.00 | $450000.00 | $664000.00 | $0.00 | $2000.00 | $63000.00 | $48000.00 | $18000.00 | $2000.00 | $461000.00 | $193000.00 | $1.02M | $1.63M | $8.12M | $236000.00 | $103000.00 | $68000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — | — | $9000.00 | $254000.00 | $736000.00 | $2.62M | $700000.00 | $408000.00 | $1.01M | $810000.00 | $670000.00 | $2.91M | $2.71M | $1.95M | $2.06M | $1.78M |
| Free cash flow | — | — | — | — | — | — | $-149000.00 | $-867000.00 | $-4.47M | $-13.30M | $-15.50M | $-6.35M | $-3.62M | $-7.23M | $-12.03M | $-19.17M | $-32.08M | $-23.76M | $-13.11M | $-10.48M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |